Search research articles
Contact Us
Filters
Showing results (81-90 of 107) with videos related to
Page
of 11
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
July 3, 2010
2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitors
Jiaqiang Cai, D Jonathan Bennett, Zoran Rankovic, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
December 3, 2023
Technical development and feasibility of a reusable vest to integrate cardiovascular magnetic resonance with electrocardiographic imaging
Matthew Webber, George Joy, Jonathan Bennett, et al.
ACS Medicinal Chemistry Letters
|
November 22, 2019
Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy
Hongjun Zhang, Kun Liu, Qinglin Pu, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2020
Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase-1 (IDO1)
Catherine White, Meredeth A McGowan, Hua Zhou, et al.
American Journal of Hematology
|
January 6, 2023
Intranasal fentanyl and discharge from the emergency department among children with sickle cell disease and vaso-occlusive pain: A multicenter pediatric emergency medicine perspective
Chris A Rees, David C Brousseau, Fahd A Ahmad, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 6, 2010
6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors
Jiaqiang Cai, Mark Baugh, Darcey Black, et al.
Chemmedchem
|
December 4, 2014
Discovery of MK-8970: an acetal carbonate prodrug of raltegravir with enhanced colonic absorption
Abbas M Walji, Rosa I Sanchez, Sophie-Dorothee Clas, et al.
American Journal of Hematology
|
September 2, 2022
Adherence to NHLBI guidelines for the emergent management of vaso-occlusive episodes in children with sickle cell disease: A multicenter perspective
Chris A Rees, David C Brousseau, Fahd A Ahmad, et al.
Molecular Cancer Therapeutics
|
November 24, 2021
STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors
Samanthi A Perera, Johnny E Kopinja, Yanhong Ma, et al.
Journal of Medicinal Chemistry
|
June 26, 2024
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRAS<sup>G12C</sup> Inhibitor
Xiaoshen Ma, David L Sloman, Ruchia Duggal, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 107) with videos related to
Sort By:
Page
of 11
Bioorganic & Medicinal Chemistry Letters
|
July 3, 2010
2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitors
Jiaqiang Cai, D Jonathan Bennett, Zoran Rankovic, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
December 3, 2023
Technical development and feasibility of a reusable vest to integrate cardiovascular magnetic resonance with electrocardiographic imaging
Matthew Webber, George Joy, Jonathan Bennett, et al.
ACS Medicinal Chemistry Letters
|
November 22, 2019
Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy
Hongjun Zhang, Kun Liu, Qinglin Pu, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2020
Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase-1 (IDO1)
Catherine White, Meredeth A McGowan, Hua Zhou, et al.
American Journal of Hematology
|
January 6, 2023
Intranasal fentanyl and discharge from the emergency department among children with sickle cell disease and vaso-occlusive pain: A multicenter pediatric emergency medicine perspective
Chris A Rees, David C Brousseau, Fahd A Ahmad, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 6, 2010
6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors
Jiaqiang Cai, Mark Baugh, Darcey Black, et al.
Chemmedchem
|
December 4, 2014
Discovery of MK-8970: an acetal carbonate prodrug of raltegravir with enhanced colonic absorption
Abbas M Walji, Rosa I Sanchez, Sophie-Dorothee Clas, et al.
American Journal of Hematology
|
September 2, 2022
Adherence to NHLBI guidelines for the emergent management of vaso-occlusive episodes in children with sickle cell disease: A multicenter perspective
Chris A Rees, David C Brousseau, Fahd A Ahmad, et al.
Molecular Cancer Therapeutics
|
November 24, 2021
STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors
Samanthi A Perera, Johnny E Kopinja, Yanhong Ma, et al.
Journal of Medicinal Chemistry
|
June 26, 2024
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRAS<sup>G12C</sup> Inhibitor
Xiaoshen Ma, David L Sloman, Ruchia Duggal, et al.
Page
of 11